Hospital
Adventist Midwest Health
Adventist Midwest Health was paid $1.24M by Medicaid between Jan 2018 and Feb 2024, across 82 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 63% of everything it billed.
33Billing provider infoADVENTIST MIDWEST HEALTH
HINSDALE, IL 60521
HINSDALE, IL 60521
33aNPI1265465439assigned 07/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.24M
24GClaims80,815
24DCodes billed82
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#44 of 129
Median peer was paid$547K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,661 | $370K | |
| 2019 | 41,280 | $602K | |
| 2020 | 11,732 | $268K | |
| 2024incomplete | 142 | $549.87 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 63% | 9,319 | 1,713 | $778K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.6% | 3,279 | 650 | $45K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.4% | 2,577 | 2,265 | $42K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.3% | 2,582 | 2,274 | $41K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.0% | 1,786 | 1,565 | $37K |
| 97161 | 2.9% | 350 | 239 | $36K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.6% | 578 | 549 | $33K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 4,383 | 4,003 | $27K |
| 80053 | Comprehensive metabolic panel | 1.8% | 6,498 | 5,354 | $23K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.3% | 1,476 | 1,306 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 8,025 | 6,430 | $15K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.1% | 2,017 | 1,775 | $14K |
70 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 1,132 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 111 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 379 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,427 | $10K |
| 86780 | <1% | 1,501 | $8K | |
| 80061 | Lipid panel | <1% | 4,067 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,894 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,970 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,732 | $4K |
| 86803 | <1% | 651 | $4K | |
| 83655 | <1% | 713 | $3K | |
| 97162 | <1% | 21 | $3K | |
| 87081 | <1% | 1,106 | $3K | |
| 87340 | <1% | 597 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 762 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 428 | $2K |
| 84439 | <1% | 960 | $2K | |
| 80081 | <1% | 114 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 106 | $2K |
| 82607 | <1% | 479 | $2K | |
| 87186 | <1% | 314 | $1K | |
| 83550 | <1% | 500 | $1K | |
| 82728 | <1% | 647 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 185 | $1K |
| 81003 | <1% | 1,553 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 129 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 38 | $1K |
| 81001 | <1% | 1,328 | $1K | |
| 84702 | <1% | 356 | $1K | |
| 85027 | <1% | 637 | $1K | |
| 82570 | <1% | 794 | $1K | |
| 83540 | <1% | 526 | $984.59 | |
| 82950 | <1% | 558 | $908.04 | |
| 87480 | <1% | 89 | $806.26 | |
| 99201 | <1% | 29 | $792.83 | |
| 84153 | <1% | 168 | $792.81 | |
| 87510 | <1% | 89 | $777.54 | |
| 80074 | <1% | 57 | $738.92 | |
| 82043 | <1% | 635 | $732.41 | |
| 87070 | <1% | 275 | $688.31 | |
| 86762 | <1% | 298 | $647.00 | |
| 86850 | <1% | 399 | $637.52 | |
| 81025 | <1% | 570 | $553.92 | |
| 86901 | <1% | 401 | $480.03 | |
| 85610 | <1% | 333 | $448.29 | |
| 87660 | <1% | 90 | $410.49 | |
| 82274 | <1% | 92 | $407.60 | |
| 86787 | <1% | 95 | $404.28 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 17 | $396.62 |
| 86900 | <1% | 400 | $362.48 | |
| 86480 | <1% | 13 | $306.28 | |
| 84480 | <1% | 93 | $302.70 | |
| 82951 | <1% | 52 | $280.85 | |
| 85652 | <1% | 361 | $268.20 | |
| 86038 | <1% | 41 | $265.21 | |
| 86140 | <1% | 129 | $202.65 | |
| 82746 | <1% | 55 | $192.74 | |
| 87808 | <1% | 28 | $177.69 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 15 | $164.08 |
| 86702 | <1% | 61 | $147.46 | |
| 84550 | <1% | 95 | $145.85 | |
| 87905 | <1% | 30 | $125.94 | |
| 84481 | <1% | 51 | $124.36 | |
| 83735 | <1% | 46 | $90.72 | |
| 82952 | <1% | 39 | $56.36 | |
| 84146 | <1% | 13 | $52.81 | |
| 82947 | <1% | 26 | $41.32 | |
| 80076 | <1% | 15 | $31.39 | |
| 80050 | General health panel | <1% | 18 | $10.65 |
| 84156 | <1% | 12 | $9.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAPMAN, CULLY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Adventist Midwest Health | La Grange, IL | $729K |
| Adventist Midwest Health | La Grange, IL | $282K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.